Alterola Biotech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Alterola Biotech generated cash of -$30,673, which is less than the previous year. Cash used in financing activities reached the amount of $40,000 last year. Net change in cash is therefore $9,327.
Cash Flow
| 2012 | 0 | 0 | 0 |
|---|---|---|---|
| 2013 | -30.67K | 0 | 40K |
ABTI Cash Flow Statement (2013 – 2014)
| 2014 | 2013 | |
|---|---|---|
Cash at beginning of period | 0 | 0 |
Operating activities | ||
Net income | -72.50K | -13.25K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 0 | 0 |
Stock-based compensation expense | 37K | 0 |
| Deferred income tax benefit | 37K | 0 |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 0 | 0 |
Inventories | 0 | 0 |
Accounts payable | 0 | 0 |
Cash generated by operating activities | -30.67K | 0 |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | 0 | 0 |
Financing activities | ||
Common Stock Issued | 0 | 0 |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | 0 | 0 |
Cash used in financing activities | 40K | 0 |
Net Change In Cash | 9.32K | 0 |
Cash at end of period | 9.32K | 0 |
| Data source | Data source |